Cite
Jia J, Chang GL, Qin S, et al. Comparative evaluation of copeptin and NT-proBNP in patients with severe acute decompensated heart failure, and prediction of adverse events in a 90-day follow-up period: A prospective clinical observation trial. Exp Ther Med. 2017;13(4):1554-1560doi: 10.3892/etm.2017.4111.
Jia, J., Chang, G. L., Qin, S., Chen, J., He, W. Y., Lu, K., Li, Y., & Zhang, D. Y. (2017). Comparative evaluation of copeptin and NT-proBNP in patients with severe acute decompensated heart failure, and prediction of adverse events in a 90-day follow-up period: A prospective clinical observation trial. Experimental and therapeutic medicine, 13(4), 1554-1560. https://doi.org/10.3892/etm.2017.4111
Jia, Jun, et al. "Comparative evaluation of copeptin and NT-proBNP in patients with severe acute decompensated heart failure, and prediction of adverse events in a 90-day follow-up period: A prospective clinical observation trial." Experimental and therapeutic medicine vol. 13,4 (2017): 1554-1560. doi: https://doi.org/10.3892/etm.2017.4111
Jia J, Chang GL, Qin S, Chen J, He WY, Lu K, Li Y, Zhang DY. Comparative evaluation of copeptin and NT-proBNP in patients with severe acute decompensated heart failure, and prediction of adverse events in a 90-day follow-up period: A prospective clinical observation trial. Exp Ther Med. 2017 Apr;13(4):1554-1560. doi: 10.3892/etm.2017.4111. Epub 2017 Feb 08. PMID: 28413508; PMCID: PMC5377512.
Copy
Download .nbib